# CORRESP — ROCKET PHARMACEUTICALS, INC.  (RCKT, RCKTW)  (CIK 0001281895)

> <strong>ROCKET PHARMACEUTICALS, INC.  (RCKT, RCKTW)  (CIK 0001281895) → SEC staff</strong> · filed 2026-03-06 · ticker RCKT, RCKTW · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001140361-26-008290
- **Form:** CORRESP
- **Filer:** ROCKET PHARMACEUTICALS, INC.  (RCKT, RCKTW)  (CIK 0001281895)
- **CIK:** 0001281895
- **Ticker:** RCKT, RCKTW
- **Filed:** 2026-03-06
- **SIC industry:** 2834
- **HQ:** New York, NY

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1281895/000114036126008290/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1281895&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for ROCKET PHARMACEUTICALS, INC.  (RCKT, RCKTW)  (CIK 0001281895)

- UPLOAD — 2026-03-06 — /comment-letter/0000000000-26-002361

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, ROCKET PHARMACEUTICALS, INC.  (RCKT, RCKTW)  (CIK 0001281895) (CIK 0001281895), filed 2026-03-06, accession 0001140361-26-008290. Retrieved via MORVS 2026-11-04 from https://api.morvs.ai/comment-letter/0001140361-26-008290.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*